ABSTRACT
A stereolithography process with thermal assistance is proposed in this work to address the tradeoff between the flowability and the high concentration of solute loadings at room temperature, through which the improved performance of polymers prepared using stereolithography 3D printing can be achieved. For the experiment, polyethylene glycol diacrylate (PEGDA) with a high molecular weight of 4000 is adopted to improve the mechanical properties of 2-Hydroxyethyl methacrylate (HEMA). For the polymer of HEMA, the highest soluble concentration of PEGDA is about 20 wt% at 25 °C (room temperature) while the concentration could be raised up to 40 wt% as the temperature increases to 60 °C. The 3D printing tests showed that the objects could be easily fabricated with the HEMA polymer loaded with 40 wt% of PEGDA through the thermally assisted projection stereolithography technology. By adding the 40 wt% of PEGDA, the Young's modulus has been enhanced by nearly 390% compared to the HEMA resin without solute, of which the Young's modulus is 63.31 ± 2.72 MPa. The results of the cell proliferation test proved that the HEMA resin loaded with PEGDA led to a better biocompatibility compared to the HEMA resin without the loading of the PEGDA solute. All of the results demonstrate that the polymer loaded with high solute is feasible to be precisely 3D-printed using the projection stereolithography process with thermal assistance, and the improved mechanical properties are beneficial for biomedical applications.
ABSTRACT
PURPOSE: Accumulating evidence indicate that antibiotic use could induce microbiome dysbiosis, which was a critical driver to the onset and progression of colorectal cancer (CRC). But the relationship between antibiotics use and CRC was still disputed. Hence, we conducted this systematic review and meta-analysis to appraise and synthesize the present available evidence to clarify the association. METHODS: PubMed, Embase, Web of Science, and Cochrane Library were systematically searched for relevant observational studies from inception to June 5, 2020. Pooled odds ratios (ORs) with 95% confidence intervals (CIs) were estimated to explore the association between antibiotics use and CRC using random-effects model. Subgroup analyses, sensitive analyses, and publication bias were conducted to assess the robust reliability of pooled results. RESULTS: A total of 15 observational studies containing 5,164,138 patients were included in this meta-analysis. The pooled analysis indicated that the total antibiotic use was correlated with increased risk of CRC (OR, 1.11; 95% CI, 1.05-1.18). The subgroup analyses suggested that antibiotic use significantly elevated risk of colon cancer, but not rectal cancer. Furthermore, we found that penicillin, cephalosporin, anti-anaerobic, and anti-aerobic antibiotics increased the risk of CRC, in particular metronidazole but no significant associations were identified in macrolide, tetracycline, sulfonamides, nitrofurans, and quinolone use. The results of sensitive analyses and publication bias indicated the conclusions were robust. CONCLUSION: The findings showed that antibiotics use may be associated with the onset of CRC. Policy-makers and clinicians should adequately assess possible benefits and harms of antibiotics use, especially in some high-risk populations. Also, for high-risk patients with previous antibiotics use, it was suggested to perform early colonoscopy screening to find or even eliminate early-stage CRC.
